AIM ImmunoTech converts third Streeterville note tranche, adding $400,000 in stock swaps
A new filing shows AIM issued 1,749,434 shares to Streeterville Capital in September 2026, adding to two earlier rounds of note-to-equity exchanges disclosed the same month.
AIM ImmunoTech Inc. disclosed a third round of debt-to-equity exchanges with lender Streeterville Capital, LLC, in a filing covering early to mid-September 2026, following two other exchange filings made earlier that month.
In the newest transaction, from September 8, 2026 to September 9, 2026, AIM ImmunoTech entered into two exchange agreements and corresponding partitioned promissory notes with Streeterville Capital, related to a promissory note dated November 18, 2025.1 Under these agreements, the company and the lender converted approximately $400,000 of the promissory note into 1,749,434 shares of common stock, at an average conversion price of approximately $0.228 per share.1
That November 2025 note had already seen an earlier conversion. In a filing covering September 3 and 4, 2026, AIM disclosed that it entered into two exchange agreements and partitioned promissory notes with Streeterville tied to the same November 18, 2025 note, converting roughly $450,000 of principal into 1,921,441 shares at an average price near $0.234 per share.2
A separate, older note was also resolved earlier in September. In a filing covering August 31 through September 3, 2026, AIM reported five exchange agreements and partitioned promissory notes with Streeterville tied to a promissory note dated February 16, 2024, under which about $1,224,341 of principal was converted into 5,065,840 shares at an average price of about $0.24 per share.3 As a result, that note was satisfied in full as of September 3, 2026, with no amounts remaining owed.3
All three rounds of conversions were carried out under the same stockholder authorization. Shareholders had approved conversion or other satisfaction of these notes under NYSE American Company Guide Sections 713(a) and 713(b) at a special meeting held on July 15, 2026.1
The shares in each transaction were issued without registration, relying on the exemption from registration requirements of the Securities Act of 1933 provided by Section 3(a)(9), covering securities exchanged with an existing security holder where no commission or other remuneration was paid for soliciting the exchange.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.